SpringerLink
Log in

Development of Breast Carcinoma in Relation to the Intrinsic Subtype

  • Chapter
  • First Online:
Pathology of Female Cancers

  • 962 Accesses

Abstract

Breast cancer is a heterogeneous disease, both histologically and genetically. Various intrinsic subtypes with different biological characteristics have been proposed. The frequency and developmental pathways of each subtype vary. Thus, non-cancerous and borderline lesions that might be related to breast cancer were examined, and their links with distinct intrinsic subtypes of breast cancer were considered. In particular, the significance of the most potent precursors (non-obligate precursors) was evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52.

    Article  CAS  PubMed  Google Scholar 

  2. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–74.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418–23. Epub 2003 Jun 26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502.

    Article  CAS  PubMed  Google Scholar 

  5. Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology. 2008;52(1):108–18.

    Article  CAS  PubMed  Google Scholar 

  6. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109(1):25–32.

    Article  CAS  PubMed  Google Scholar 

  7. Tischkowitz M, Brunet JS, Bégin LR, Huntsman DG, Cheang MC, Akslen LA, Nielsen TO, Foulkes WD. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer. 2007;7:134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5(1):5–23.

    Article  CAS  PubMed  Google Scholar 

  9. Mayer IA, Abramson VG, Lehmann BD, Pietenpol JA. New strategies for triple-negative breast cancer—deciphering the heterogeneity. Clin Cancer Res. 2014;20(4):782–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ, Members P. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F, Kinoshita T, Takei H, Takahashi K, Ikeda M, Nakashima K. The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast. 2007;16(Suppl 2):S72–7.

    Article  PubMed  Google Scholar 

  12. Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J. 2007;13(2):115–21.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Kim E, Albashiti B, Sharaf Aldeen B, Radisky DC, Frost MH, Visscher DW, Hartmann LC, Nassar WH, Ali-Femhi R. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila). 2012;5(12):1375–80.

    Article  Google Scholar 

  14. Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson SD, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF. Association between benign breast disease in African American and white American women and subsequent triple-negative breast cancer. JAMA Oncol. 2017;3(8):1102–6.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Perou CM. Molecular stratification of triple-negative breast cancers. Oncologist. 2010;15(Suppl 5):39–48.

    Article  CAS  PubMed  Google Scholar 

  16. Oh H, Eliassen AH, Wang M, Smith-Warner SA, Beck AH, Schnitt SJ, Collins LC, Connolly JL, Montaser-Kouhsari L, Polyak K, Tamimi RM. Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer. NPJ Breast Cancer. 2016;2:pii: 16032. https://doi.org/10.1038/npjbcancer.2016.32. Epub 2016 Oct 26.

    Article  Google Scholar 

  17. Woolcott CG, SenGupta SK, Hanna WM, Aronson KJ. Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls. BMC Cancer. 2008;8:130. https://doi.org/10.1186/1471-2407-8-130.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Moriya T, Kanomata N, Kozuka Y, Hirakawa H, Kimijima I, Kimura M, Watanabe M, Sasano H, Ishida T, Ohuchi N, Kurebayashi J, Sonoo H. Molecular morphological approach to the pathological study of development and advancement of human breast cancer. Med Mol Morphol. 2010;43(2):67–73.

    Article  CAS  PubMed  Google Scholar 

  19. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.

    Article  CAS  PubMed  Google Scholar 

  20. Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569–75.

    Article  CAS  PubMed  Google Scholar 

  21. Donaldson AR, McCarthy C, Goraya S, Pederson HJ, Sturgis CD, Grobmyer SR, Calhoun BC. Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy. Cancer. 2017;124:459. https://doi.org/10.1002/cncr.31061. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  22. McEvoy MP, Coopey SB, Mazzola E, Buckley J, Belli A, Polubriaginof F, Merrill AL, Tang R, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi AJ, Roche CA, Hughes KS. Breast cancer risk and follow-up recommendations for young women diagnosed with atypical hyperplasia and lobular carcinoma in situ (LCIS). Ann Surg Oncol. 2015;22(10):3346–9.

    Article  PubMed  Google Scholar 

  23. Dion L, Racin A, Brousse S, Beltjens F, Cauchois A, Levêque J, Coutant C, Lavoué V. Atypical epithelial hyperplasia of the breast: state of the art. Expert Rev Anticancer Ther. 2016;16(9):943–53.

    Article  CAS  PubMed  Google Scholar 

  24. Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Breast cancer risk by extent and type of atypical hyperplasia: an update from the Nurses’ Health Studies. Cancer. 2016;122(4):515–20.

    Article  PubMed  Google Scholar 

  25. Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):307–17.

    Article  CAS  PubMed  Google Scholar 

  26. Daoud SA, Ismail WM, Abdelhamid MS, Nabil TM, Daoud SA. Possible prognostic role of HER2/Neu in ductal carcinoma in situ and atypical ductal proliferative lesions of the breast. Asian Pac J Cancer Prev. 2016;17(8):3733–6.

    PubMed  Google Scholar 

  27. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100(2):238–44.

    Article  PubMed  Google Scholar 

  28. Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23(24):5534–41.

    Article  PubMed  Google Scholar 

  29. Boulos FI, Dupont WD, Schuyler PA, Sanders ME, Page DL, Fedda FA, Simpson JF. Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions: evidence against a precursor role. Cancer. 2012;118(9):2372–7.

    Article  PubMed  Google Scholar 

  30. Said SM, Visscher DW, Nassar A, Frank RD, Vierkant RA, Frost MH, Ghosh K, Radisky DC, Hartmann LC, Degnim AC. Flat epithelial atypia and risk of breast cancer: a Mayo cohort study. Cancer. 2015;121(10):1548–55.

    Article  PubMed  Google Scholar 

  31. Brandt SM, Young GQ, Hoda SA. The “Rosen Triad”: tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions. Adv Anat Pathol. 2008;15(3):140–6.

    Article  PubMed  Google Scholar 

  32. Meares AL, Frank RD, Degnim AC, Vierkant RA, Frost MH, Hartmann LC, Winham SJ, Visscher DW. Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases. Hum Pathol. 2016;49:33–8.

    Article  PubMed  Google Scholar 

  33. Zhang G, Ataya D, L Lebda P, Calhoun BC. Mucocele-like lesions diagnosed on breast core biopsy: low risk of upgrade and subsequent carcinoma. Breast J. 2017. https://doi.org/10.1111/tbj.12929. [Epub ahead of print].

  34. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010;57(2):171–92.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by JSPS KAKENHI Grant Grant-in-Aid for Scientific Research (C), Numbers JP25460467 and JP16K08701.

Author information

Authors and Affiliations

  1. Department of Pathology, Kawasaki Medical School, Kurashiki, Okayama, Japan

    Takuya Moriya

Authors
  1. Takuya Moriya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuya Moriya .

Editor information

Editors and Affiliations

  1. Department of Pathology, Kawasaki Medical School, Kurashiki, Japan

    Takuya Moriya

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moriya, T. (2018). Development of Breast Carcinoma in Relation to the Intrinsic Subtype. In: Moriya, T. (eds) Pathology of Female Cancers. Springer, Singapore. https://doi.org/10.1007/978-981-10-8606-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8606-9_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-8605-2

  • Online ISBN: 978-981-10-8606-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation